Search Results - "Kayed, R."

Refine Results
  1. 1

    Tau oligomers as potential targets for immunotherapy for Alzheimer's disease and tauopathies by Lasagna-Reeves, C A, Castillo-Carranza, D L, Jackson, G R, Kayed, R

    Published in Current Alzheimer research (01-09-2011)
    “…The aggregation and accumulation of the microtubule-associated protein (Tau) is a pathological hallmark of Alzheimer disease (AD) and many neurodegenerative…”
    Get more information
    Journal Article
  2. 2
  3. 3

    Formation of immunoglobulin light chain amyloid oligomers in primary cutaneous nodular amyloidosis by Clos, A.L., Lasagna-Reeves, C.A., Castillo-Carranza, D.L., Sengupta, U., Jackson, G.R., Kelly, B., Beachkofsky, T.M., Kayed, R.

    Published in British journal of dermatology (1951) (01-12-2011)
    “…Summary Background  Primary cutaneous nodular amyloidosis (PCNA) is thought to be a plasma cell dyscrasia. The amyloid deposits are found in the dermis and…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Effects of Gum Arabic in rats with adenine-induced chronic renal failure by Ali, Badreldin H, Al-Salam, Suhail, Al Husseni, Isehaq, Kayed, Rana R, Al-Masroori, Noura, Al-Harthi, Thuriya, Al Zaabi, Mohamed, Nemmar, Abderrahim

    “…Gum Arabic (GA [Acacia senegal]) is reputed, in Arabian medicinal practices, to be useful in treating patients with chronic renal failure (CRF), albeit without…”
    Get more information
    Journal Article
  6. 6

    A specific amyloid-β protein assembly in the brain impairs memory by Glabe, Charles G, Kotilinek, Linda, Gallagher, Michela, Koh, Ming Teng, Ashe, Karen H, Kayed, Rakez, Lesné, Sylvain, Yang, Austin

    Published in Nature (16-03-2006)
    “…Memory function often declines with age, and is believed to deteriorate initially because of changes in synaptic function rather than loss of neurons. Some…”
    Get full text
    Journal Article
  7. 7

    Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis by Glabe, Charles G, Kayed, Rakez

    Published in Neurology (24-01-2006)
    “…Recent findings indicate that soluble amyloid oligomers may represent the primary pathologic species in degenerative diseases. These amyloid oligomers share…”
    Get full text
    Journal Article
  8. 8

    Calcium Dysregulation and Membrane Disruption as a Ubiquitous Neurotoxic Mechanism of Soluble Amyloid Oligomers by Demuro, Angelo, Mina, Erene, Kayed, Rakez, Milton, Saskia C., Parker, Ian, Glabe, Charles G.

    Published in The Journal of biological chemistry (29-04-2005)
    “…Increasing evidence suggests that amyloid peptides associated with a variety of degenerative diseases induce neurotoxicity in their intermediate oligomeric…”
    Get full text
    Journal Article
  9. 9

    Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo by Yang, Fusheng, Lim, Giselle P., Begum, Aynun N., Ubeda, Oliver J., Simmons, Mychica R., Ambegaokar, Surendra S., Chen, Pingping P., Kayed, Rakez, Glabe, Charles G., Frautschy, Sally A., Cole, Gregory M.

    Published in The Journal of biological chemistry (18-02-2005)
    “…Alzheimer's disease (AD) involves amyloid β (Aβ) accumulation, oxidative damage, and inflammation, and risk is reduced with increased antioxidant and…”
    Get full text
    Journal Article
  10. 10

    Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles: Intracellular Aβ and Synaptic Dysfunction by Oddo, Salvatore, Caccamo, Antonella, Shepherd, Jason D, Murphy, M.Paul, Golde, Todd E, Kayed, Rakez, Metherate, Raju, Mattson, Mark P, Akbari, Yama, LaFerla, Frank M

    Published in Neuron (Cambridge, Mass.) (31-07-2003)
    “…The neuropathological correlates of Alzheimer's disease (AD) include amyloid-β (Aβ) plaques and neurofibrillary tangles. To study the interaction between Aβ…”
    Get full text
    Journal Article
  11. 11

    Permeabilization of Lipid Bilayers Is a Common Conformation-dependent Activity of Soluble Amyloid Oligomers in Protein Misfolding Diseases by Kayed, Rakez, Sokolov, Yuri, Edmonds, Brian, McIntire, Theresa M, Milton, Saskia C, Hall, James E, Glabe, Charles G

    Published in The Journal of biological chemistry (05-11-2004)
    “…Amyloid fibrillization is multistep process involving soluble oligomeric intermediates, including spherical oligomers and protofibrils. Amyloid oligomers have…”
    Get full text
    Journal Article
  12. 12

    Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis by Kayed, Rakez, Head, Elizabeth, Thompson, Jennifer L., McIntire, Theresa M., Milton, Saskia C., Cotman, Carl W., Glabe, Charles G.

    “…Soluble oligomers are common to most amyloids and may represent the primary toxic species of amyloids, like the Aβ peptide in Alzheimer's disease (AD). Here we…”
    Get full text
    Journal Article
  13. 13

    Methylene Blue Inhibits Amyloid Aβ Oligomerization by Promoting Fibrillization by Necula, Mihaela, Breydo, Leonid, Milton, Saskia, Kayed, Rakez, van der Veer, Wytze E, Tone, Paul, Glabe, Charles G

    Published in Biochemistry (Easton) (31-07-2007)
    “…Amyloid plaques are hallmark neuropathological lesions in Alzheimer's disease, which consist of abnormally aggregated Aβ protein. Multiple Aβ aggregated…”
    Get full text
    Journal Article
  14. 14

    Drusen deposits associated with aging and age-related macular degeneration contain nonfibrillar amyloid oligomers by Luibl, Volker, Isas, Jose M, Kayed, Rakez, Glabe, Charles G, Langen, Ralf, Chen, Jeannie

    Published in The Journal of clinical investigation (01-02-2006)
    “…Protein misfolding and aggregation are thought to underlie the pathogenesis of many amyloid diseases, such as Alzheimer and Parkinson diseases, whereby a…”
    Get full text
    Journal Article
  15. 15

    Prefilament tau species as potential targets for immunotherapy for Alzheimer disease and related disorders by Kayed, Rakez, Jackson, George R

    Published in Current opinion in immunology (01-06-2009)
    “…Alzheimer disease (AD) is the most common neurodegenerative disorder. Currently available therapies may slow cognitive decline but do not alter underlying…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Desmin-Related Cardiomyopathy in Transgenic Mice: A Cardiac Amyloidosis by Sanbe, Atsushi, Osinska, Hanna, Saffitz, Jeffrey E., Glabe, Charles G., Kayed, Rakez, Maloyan, Alina, Robbins, Jeffrey, Olson, Eric N.

    “…An R120G missense mutation in the small heat shock protein α-B-crystallin ( CryAB R120 G) causes desmin-related cardiomyopathy (DRM). DRM is characterized by…”
    Get full text
    Journal Article
  18. 18

    Soluble Aβ oligomers ultrastructurally localize to cell processes and might be related to synaptic dysfunction in Alzheimer's disease brain by Kokubo, Hideko, Kayed, Rakez, Glabe, Charles G., Yamaguchi, Haruyasu

    Published in Brain research (21-01-2005)
    “…Soluble Aβ oligomers have recently been considered to be responsible for cognitive dysfunction prior to senile plaque (SP) formation in Alzheimer's disease…”
    Get full text
    Journal Article
  19. 19

    Poloxamer 188 Copolymer Membrane Sealant Rescues Toxicity of Amyloid Oligomers In Vitro by Mina, Erene W., Lasagna-Reeves, Cristian, Glabe, Charles G., Kayed, Rakez

    Published in Journal of molecular biology (21-08-2009)
    “…Amyloid oligomers and protofibrils increase cell membrane permeability, eventually leading to cell death. Here, we demonstrate that amyloid oligomer toxicity…”
    Get full text
    Journal Article
  20. 20

    Reversal of Amyloid-Induced Heart Disease in Desmin-Related Cardiomyopathy by Sanbe, Atsushi, Osinska, Hanna, Villa, Chet, Gulick, James, Klevitsky, Raisa, Glabe, Charles G., Kayed, Rakez, Robbins, Jeffrey, Olson, Eric N.

    “…Amyloid oligomers, similar to the toxic entities found in Alzheimer's disease patients and in other amyloid-based diseases, are present in cardiomyocytes…”
    Get full text
    Journal Article